EGFR and colorectal carcinoma: To obtain a comprehensive and full picture of the RAS status of CRC cases treated by EGFR-targeted therapy at times when only KRAS exon 2 testing was required, we performed targeted next generation sequencing (tNGS), including all 24 primary tumors, 3 recurrent tumors and 20 distant liver or lung metastases.